April 8, 2022 -- Life sciences company Vizgen announced that it will showcase data for understanding the tumor microenvironment from its spatial genomics platform Merscope at the American Association for Cancer Research (AACR) Annual Meeting, held April 8-13.
Specifically, the company said that it will share data from in situ single-cell transcriptomic imaging in formalin-fixed paraffin-embedded tissue sections using Merscope.
In addition, the company will present a poster presentation on how a spatially resolved map of colorectal cancer can best identify novel spatial relationships between cancer cells and the microenvironment, it said. The work was conducted with Massachusetts General Hospital.
Copyright © 2022 scienceboard.net